Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies

Bibliography

• STEMMER WP, HOLLAND B: Survival of the fittest molecule. Am. Sci. (2003) 91:526–533.
   Web of Science ®Google Scholar
• •A current review of the broad applications of directed molecular evolution using DNA shuffling and screening strategies.
   Google Scholar
• PATTEN PA, HOWARD RI, STEMMER WP: Applications of DNA shuffling to pharmaceuticals and vaccines. Cuir. Opin. Biotechnol (1997) 8:724–733.
   PubMed Web of Science ®Google Scholar
• WHALEN RG, KAIWAR R, SOONG NW, PUNNONENJ: DNA shuffling and vaccines. Cuir. Opin. Mol Ther. (2001) 3:31–36.
   PubMed Web of Science ®Google Scholar
• CIUREA A, HUNZIKER L, MARTINIC MM, OXENIUS A, HENGARTNER H, ZINKERNAGEL RM: CD4+ T-cell-epitope escape mutant virus selectedin vivo. Nat. Med (2001) 7:795–800.
   PubMed Web of Science ®Google Scholar
• •An important study showing that viral escape from T helper cell responses during a viral infection may contribute to a persistent infection.
   Google Scholar
• ECKELS DD, WANG H, BIAN TH, TABATABAI N, GILL JC: Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection. Immunol Rev (2000) 174:90–97.
   PubMed Web of Science ®Google Scholar
• O'CONNOR DH, ALLEN TM, VOGEL TU et al.: Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med (2002) 8:493–499.
   Google Scholar
• •A key study showing that the cytotoxic T lymphocytes select for escape variants early in SW infection.
   Google Scholar
• WALKER BD, KORBER BT: Immune control of HIV: the obstacles of HLA and viral diversity. Nat. Inman. (2001) 2:473–475.
   PubMed Web of Science ®Google Scholar
• POWERS AM, BRAULT AC, SHIRAKO Yet al.: Evolutionary relationships and systematics of the alphaviruses. Vim/. (2001) 75:10118–10131.
   Google Scholar
• BRAULT AC, POWERS AM, CHAVEZ CL et al: Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America. Am. I Trop. Med. Hyg. (1999) 61:579–586.
   PubMed Web of Science ®Google Scholar
• KINNEY RIVI, PFEFFER M, TSUCHIYA KR, CHANG GJ, ROEHRIG JT: Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex. Am. J. Trop. Med. Hyg. (1998) 59:952–964.
   PubMed Web of Science ®Google Scholar
• TWIDDY SS, HOLMES EC, RAMBAUT A: Inferring the rate and time-scale of dengue virus evolution. Ma Biol. Evol (2003) 20:122–129.
   PubMed Web of Science ®Google Scholar
• DIAZ FJ, FARFAN-ALE JA, OLSON KE et al: Genetic variation within the premembrane coding region of dengue viruses from the Yucatan peninsula of Mexico. Am. I Trop. Med. Hyg. (2002) 67:93–101.
   PubMed Web of Science ®Google Scholar
• HAHN YS: Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? Cup-. Opin. Immunol (2003) 15:443–449.
   PubMed Web of Science ®Google Scholar
• KORBER B, GASCHEN B, YUSIM K, THAKALLAPALLY R, KESMIR C, DETOURS V: Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. (2001) 58:19–42.
   PubMed Web of Science ®Google Scholar
• NOWAK MA, ANDERSON RM, BOERLIJST MC, BONHOEFFER S, MAY RM, MCMICHAEL AJ: HIV-1 evolution and disease progression. Science (1996) 274:1008–1011.
   PubMed Web of Science ®Google Scholar
• HALPERN AL: Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine. J. Clin. Vim/ (2000) 19:43–56.
   Google Scholar
• YAMADA T, MANOS MM, PETO J et al: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.' Viral. (1997) 71:2463–2472.
   PubMed Web of Science ®Google Scholar
• FERGUSON NM, GALVANI AP, BUSH RM: Ecological and immunological determinants of influenza evolution. Nature (2003) 422:428–433.
   PubMed Web of Science ®Google Scholar
• ZAMBON MC: Epidemiology and pathogenesis of influenza. J. Antimicrob. Chemother. (1999) 44(Suppl. B):3–9.
   Google Scholar
• OLSZEWSKA W, ZAMBON M, OPENSHAW PJ: Development of vaccines against common colds. Br. Med. Bull. (2002) 62:99–111.
   PubMed Web of Science ®Google Scholar
• SULLENDER WM: Respiratory syncytial virus genetic and antigenic diversity. Clin. Microbial Rev (2000) 13:1–15
   PubMed Web of Science ®Google Scholar
• DIETZSCHOLD B, RUPPRECHT CE, TOLLIS M et al.: Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev Infect. Dis. (1988) 10\(Suppl. 4):5785–5798.
   Google Scholar
• DIWAKARLA S, CLARK R, PALOMBO EA: Expanding distribution of human serotype G6 rotaviruses in Australia. Microbial Immunal (2002) 46:499–502.
   PubMed Web of Science ®Google Scholar
• PADILLA-NORIEGA L, MENDEZ-TOSS M, MENCHACA G et al.: Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico." Clin. Microbial (1998) 36:1688–1692.
   Google Scholar
• BAYLISS CD, FIELD D, MOXON ER: The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. I Clin. Invest. (2001) 107:657–662.
   PubMed Web of Science ®Google Scholar
• ROKBI B, RENAULD-MONGENIE G, MIGNON M et al.: Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect. Immun. (2000) 68:4938–4947.
   PubMed Web of Science ®Google Scholar
• DERRICK JP, URWIN R, SUKER J, FEAVERS IM, MAIDEN MC: Structural and evolutionary inference from molecular variation in Neisseria porins. Infect. Immun. (1999) 67:2406–2413.
   PubMed Web of Science ®Google Scholar
• HAAKE DA: Spirochaetal lipoproteins and pathogenesis. Microbiology (2000) 146:1491–1504.
   PubMed Web of Science ®Google Scholar
• GILSDORF JR: Antigenic diversity and gene polymorphisms in Haemophilus influenzae. Infect. Inman. (1998) 66:5053–5059.
   PubMed Web of Science ®Google Scholar
• LADEFOGED SA: Molecular dissection ofMycoplasma hominis. APMIS Suppl (2000) 97:1–45.
   PubMedGoogle Scholar
• STRINGER JR, KEELY SP: Genetics of surface antigen expression in Pneumocystis carinii Infect. Immun. (2001) 69:627–639.
   Google Scholar
• BEARD CB, CARTER JL, KEELY SP et al.: Genetic variation in Pneumocystis cariniiisolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. (2000) 6:265–272.
   PubMed Web of Science ®Google Scholar
• MAIZELS RM, KURNIAWAN-ATMADJA A: Variation and polymorphism in helminth parasites. Parasitology (2002) 125(Suppl.):S25–S37.
   Google Scholar
• TURNER CM: Antigenic variation in Trypanosoma bruceiinfections: an holistic view. J. Cell Sci. (1999) 112:3187–3192.
   PubMed Web of Science ®Google Scholar
• BEESON JG, BROWN GV: Pathogenesis of Plasmodium fakiparum malaria: the roles of parasite adhesion and antigenic variation. Mal Life Sci (2002) 59:258–271.
   PubMed Web of Science ®Google Scholar
• KYES S, HORROCKSP, NEWBOLD C: Antigenic variation at the infected red cell surface in malaria. Ann. Rev Microbial (2001) 55:673–707.
   PubMed Web of Science ®Google Scholar
• •A thorough review of the role of antigenic variation in malaria infection.
   Google Scholar
• NASH TE: Surface antigenic variation inGiardia lamblia. Mal Microbial (2002) 45:585–590.
   PubMed Web of Science ®Google Scholar
• NASH TE, LUJAN HT, MOWATT MR, CONRAD JT: Variant-specific surface protein switching in Giardia lamblia. Infect. Inman. (2001) 69:1922–1923.
   PubMed Web of Science ®Google Scholar
• BORST P: Antigenic variation and allelic exclusion. Cell (2002) 109:5–8.
   PubMed Web of Science ®Google Scholar
• •A concise summary of the molecular mechanisms involved in antigenic variation.
   Google Scholar
• YOUNG D, HUSSELL T, DOUGAN G: Chronic bacterial infections: living with unwanted guests. Nat. Inman. (2002) 3:1026–1032.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of the mechanisms ofantigenic variation that uses many examples of bacterial infections.
   Google Scholar
• BARBOUR AG, RESTREPO BI: Antigenic variation in vector-borne pathogens. Emerg. Infect. Dis. (2000) 6:449–457.
   PubMed Web of Science ®Google Scholar
• CAPIAU C, POOLMAN J, HOET B, BOGAERTS H, ANDRE F: Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned. Vaccine (2003) 21:2273–2287.
   PubMed Web of Science ®Google Scholar
• BILLICH A: HPV vaccine MedImmune/ GlaxoSmithKline. Carr: Opin. Investig. Drugs (2003) 4:210–213.
   PubMedGoogle Scholar
• OBARO SK: The new pneumococcal vaccine. Clin. Microbial Infect. (2002) 8:623–633.
   PubMed Web of Science ®Google Scholar
• STEMMER WP: Rapid evolution of a protein in vitro by DNA shuffling. Nature (1994) 370:389–391.
   PubMed Web of Science ®Google Scholar
• •A study showing that antibiotic resistance molecules can be evolved using DNA shuffling and screening strategies.
   Google Scholar
• STEMMER WP: DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. USA (1994) 91:10747–10751.
   PubMed Web of Science ®Google Scholar
• MINSHULL J, STEMMER WP: Protein evolution by molecular breeding. Carr: Opin. Chem. Biol. (1999) 3:284–290.
   PubMed Web of Science ®Google Scholar
• KURTZMAN AL, GOVINDARAJAN S, VAHLE K, JONES JT, HEINRICHS V, PATTEN PA: Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins. Carr: Opin. Biatechnol (2001) 12:361–370.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of directedevolution using DNA shuffling and screening strategies.
   Google Scholar
• ZHANGJH, DAWES G, STEMMER WP:Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening. Proc. Nati Acad. Sci. USA (1997) 94:4504–4509.
   PubMed Web of Science ®Google Scholar
• CHANG CC, CHEN TT, COX BW et al.: Evolution of a cytokine using DNA family shuffling. Nat. Biotechnol (1999) 17:793–797.
   PubMed Web of Science ®Google Scholar
• YANG S, BRINKMAN A, SEMYONOV A, DAWES G, PUNNONEN J, APT D: Antibody responses in mice immunized with shuffled tetravalent dengue antigens. American Society for Tropical Medicine and Hygiene 51st Annual Meeting. November 10–14, 2002. Denver, CO, USA.
   Google Scholar
• BARUCH DI, PASLOSKE BL, SINGH HB et al.: Cloning the 1? fakiparum gene encoding PIEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell (1995) 82:77–87.
   PubMed Web of Science ®Google Scholar
• CHEN Q, FERNANDEZ V, SUNDSTROM A et al.: Developmental selection of var gene expression in Plasmodium fakiparum. Nature (1998) 394:392–395.
   PubMed Web of Science ®Google Scholar
• SCHERF A, HERNANDEZ-RIVAS R, BUFFET P et al.: Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium fakiparum. EMBO J. (1998) 17:5418–5426.
   PubMed Web of Science ®Google Scholar
• CALDERWOOD MS, GANNOUN-ZAKI L, WELLEMS TE, DEITSCH KW: Plasmodium fakiparum var genes are regulated by two regions with separate promoters, one upstream of the coding region and a second within the intron. I Biol. Chem. (2003) 278:34125–34132.
   Web of Science ®Google Scholar
• BULL PC, LOWE BS, KORTOK M, MOLYNEUX CS, NEWBOLD CI, MARSH K: Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med (1998) 4:358–360.
   PubMed Web of Science ®Google Scholar
• KINYANJUI SM, BULL P, NEWBOLD CI, MARSH K: Kinetics of antibody responses to Plasmodium fakiparum-infected erythrocyte variant surface antigens. J. Infect. Dis. (2003) 187:667–674.
   PubMed Web of Science ®Google Scholar
• BARUCH DI, MA XC, SINGH HB, BI X,PASLOSKE BL, HOWARD RJ: Identification of a region of PIEMP1 that mediates adherence of Plasmodium fakiparum infected erythrocytes to CD36: conserved function with variant sequence. Blood(1997) 90:3766–3775.
   PubMed Web of Science ®Google Scholar
• MILLER LH, BARUCH DI, MARSH K, DOUMBO OK: The pathogenic basis of malaria. Nature (2002) 415:673–679.
   PubMed Web of Science ®Google Scholar
• •A detailed and up to date review of the pathogenesis of malaria and the role of antigenic variation.
   Google Scholar
• BARUCH DI, GAMAIN B, BARNWELL JW et al: Immunization of Aotus monkeys with a functional domain of the Plasmodium fakiparum variant antigen induces protection against a lethal parasite line. Proc. Nati Acad. Sci. USA (2002) 99:3860–3865.
   PubMed Web of Science ®Google Scholar
• LOCHER CP, HEINRICHS V, BASS S et al.: DNA shuffling of Plasmodium fakiparum erythrocyte membrance protein-1 genes produces multiple variants that induce broadly cross reactive antibodies. American Society for Tropical Medicine and Hygiene 52nd Annual Meeting. December 3–7, 2003. Philadelphia, PA, USA.
   Google Scholar
• NARA PL, GARRITY RR, GOUDSMITJ: Neutralization of HIV-1: a paradox of humoral proportions. FASEB J. (1991) 5:2437–2455.
   PubMed Web of Science ®Google Scholar
• BURTON DR: Antibodies, viruses and vaccines. Nat. Rev Immunol (2002) 2:706–713.
   PubMed Web of Science ®Google Scholar
• DU X, XU L, ZHANG W et al.: Creating novel HIV-1 gp120 and gp120 core molecules sharing similar antigenicity to native trimeric envelope complex using DNA shuffling technology. 10th Conference on Retro viruses and Opportunistic Infections February 10–14, 2003, Boston, MA, USA.
   Google Scholar
• WHALEN RG, BEARD C, XU L, SBAI H: Creation of chimeric hepatitis B virus surface antigens with novel immunogenicities using DNA shuffling and screening technologies. Falk Symposium No. 138. State of the Art of Hepatology: Molecular and Cell Biology October 20–21, 2003. Freiburg, Germany.
   Google Scholar
• SIN JI, KIM J, CHATTERGOON M: Engineering of DNA vaccines using molecular adjuvant plasmids. Dev. Biol. (Basel). (2000) 104:187–198.
   PubMedGoogle Scholar
• VOSS G, VILLINGER F: Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS. AIDS (2000) 14\(Suppl. 3):5153–5165.
   Google Scholar
• LAZETIC S, LEONG SR, CHANG JC, ONG R, DAWES G, PUNNONEN J: Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells. Biol. Chem. (2002) 277:38660–38668.
   Web of Science ®Google Scholar
• ••An important study showing the evolution of a costirnulatory molecule that is useful in a combined vaccine strategy as a genetic adjuvant.
   Google Scholar
• LEONG SR, CHANG JC, ONG R, DAWES G, STEMMER WP, PUNNONEN J: Optimized expression and specific activity of IL-12 by directed molecular evolution. Proc. Nati Acad. Sci. USA (2003) 100:1163–1168.
   PubMed Web of Science ®Google Scholar
• ••An important study showing an evolvedIL-12 that has significantly improved properties over human IL-12 and that can serve as a genetic adjuvant when coadministered with a vaccine.
   Google Scholar
• MAKRIDES SC: Strategies for achieving high-level expression of genes in Escherichia coil. Microbiol Rev (1996) 60:512–538.
   PubMedGoogle Scholar
• SAWERS G, JARSCH M: Alternative regulation principles for the production of recombinant proteins in Escherichia coil. Appl. Microbiol Biotechnol (1996) 46:1–9.
   PubMed Web of Science ®Google Scholar
• HANNIG G, MAKRIDES SC: Strategies for optimizing heterologous protein expression in Escherichia coil. Trends Biotech. (1998) 16:54–60.
   PubMed Web of Science ®Google Scholar
• SCHEIN CH: Solubility and secretability. Curr. Opin. Biotechnol. (1993) 4:456–461.
   PubMedGoogle Scholar
• PEKRUN K, SHIBATA R, IGARASHI T et al.: Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shuffling. J. Virol (2002) 76:2924–2935.
   PubMed Web of Science ®Google Scholar
• •This study showed that shuffling and screening strategies can be used to develop viral variants having altered tropism and improved replication capacity in monkey peripheral blood mononuclear cells.
   Google Scholar
• POWELL SK, KALOSS MA, PINKSTAFF A: Breeding of retroviruses by DNA shuffling for improved stability and processing yields. Nat. Biotechnol (2000) 18:1279–1282.
   PubMed Web of Science ®Google Scholar